LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Link
http://www.nature.com/articles/s41419-018-0869-2.pdf
Reference60 articles.
1. Yeo, S. K. & Guan, J. L. Breast cancer: multiple subtypes within a tumor? Trends Cancer 3, 753–760 (2017).
2. O’Reilly, E. A. et al. The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin. 3, 257–275 (2015).
3. Greenup, R. et al. Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. Ann. Surg. Oncol. 20, 3254–3258 (2013).
4. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750–2767 (2011).
5. Von Minckwitz, G. & Martin, M. Neoadjuvant treatments for triple-negative breast cancer (TNBC). Ann. Oncol. 23, vi35–39 (2012).
Cited by 123 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Beyond the Genome: Deciphering the Role of MALAT1 in Breast Cancer Progression;Current Genomics;2024-10
2. LINC01503 promotes the cell proliferation, migration and invasion of triple-negative breast cancer as a ceRNA to elevate SPNS2 expression by sponging miR-335–5p;Heliyon;2024-09
3. Cardiovascular and genetic determinants of platelet high responsiveness: results from the Gutenberg Health Study;Blood Advances;2024-07-24
4. TYMS Knockdown Suppresses Cells Proliferation, Promotes Ferroptosis via Inhibits PI3K/Akt/mTOR Signaling Pathway Activation in Triple Negative Breast Cancer;Cell Biochemistry and Biophysics;2024-07-04
5. LncRNA MIR100HG affects the proliferation and metastasis of lung cancer cells through mediating the microRNA‐5590‐3p/DCBLD2 axis;Immunity, Inflammation and Disease;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3